Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wronski

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neuro-Degenerative Diseases|March 7, 2008
The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies?M Windisch, H Wolf, B Hutter-Paier, et al.
Annals of the New York Academy of Sciences|November 15, 2021
Math anxiety differentially impairs symbolic, but not nonsymbolic, fraction skills across developmentIsabella Starling-Alves, Matthew R Wronski, Edward M Hubbard
Deutsche Medizinische Wochenschrift (1946)|June 21, 1974
[Transitory myocardial damage by chlorinated hydrocarbons (author's transl)]K G Ravens, H Steer, R Wronski, et al.
Klinische Wochenschrift|July 1, 1983
Near fatal percutaneous paraquat poisoningS Okonek, R Wronski, W Niedermayer, et al.
Die Medizinische Welt|July 10, 1981
[Effect of hemoperfusion on the blood coagulation system]R Wronski, H D Bruhn, J P Albert, et al.
Journal of Neural Transmission. Supplementum|August 29, 2000
A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neuronsR Wronski, S Kronawetter, B Hutter-Paier, et al.
Current Alzheimer Research|October 3, 2007
Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?M Windisch, H J Wolf, B Hutter-Paier, et al.
Journal of Medicine and Life|April 14, 2015
Long-term treatment of aged Long Evans rats with a dietary supplement containing neuroprotective peptides (N-PEP-12) to prevent brain aging: effects of three months daily treatment by oral gavageB Hutter-Paier, B Reininger-Gutmann, R Wronski, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 10, 2000
Inhibitory effect of a brain derived peptide preparation on the Ca++-dependent protease, calpainR Wronski, P Tompa, B Hutter-Paier, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 22, 2005
A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxicationC Riley, B Hutter-Paier, M Windisch, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neuro-Degenerative Diseases|March 7, 2008
The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies?M Windisch, H Wolf, B Hutter-Paier, et al.
Annals of the New York Academy of Sciences|November 15, 2021
Math anxiety differentially impairs symbolic, but not nonsymbolic, fraction skills across developmentIsabella Starling-Alves, Matthew R Wronski, Edward M Hubbard
Deutsche Medizinische Wochenschrift (1946)|June 21, 1974
[Transitory myocardial damage by chlorinated hydrocarbons (author's transl)]K G Ravens, H Steer, R Wronski, et al.
Klinische Wochenschrift|July 1, 1983
Near fatal percutaneous paraquat poisoningS Okonek, R Wronski, W Niedermayer, et al.
Die Medizinische Welt|July 10, 1981
[Effect of hemoperfusion on the blood coagulation system]R Wronski, H D Bruhn, J P Albert, et al.
Journal of Neural Transmission. Supplementum|August 29, 2000
A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neuronsR Wronski, S Kronawetter, B Hutter-Paier, et al.
Current Alzheimer Research|October 3, 2007
Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?M Windisch, H J Wolf, B Hutter-Paier, et al.
Journal of Medicine and Life|April 14, 2015
Long-term treatment of aged Long Evans rats with a dietary supplement containing neuroprotective peptides (N-PEP-12) to prevent brain aging: effects of three months daily treatment by oral gavageB Hutter-Paier, B Reininger-Gutmann, R Wronski, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 10, 2000
Inhibitory effect of a brain derived peptide preparation on the Ca++-dependent protease, calpainR Wronski, P Tompa, B Hutter-Paier, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 22, 2005
A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxicationC Riley, B Hutter-Paier, M Windisch, et al.
Pageof 3